Mycophenolate mofetil in dysimmune neuropathies: A preliminary study

被引：39

作者：

Benedetti, L ^{[1
]}

Grandis, M

Nobbio, L

Beronio, A

Ghiglione, E

Manzino, M

Primavera, A

Mancardi, G

Schenone, A

机构：

[1] Univ Genoa, Dept Neurosci Opthalmol & Genet, Genoa, Italy

[2] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy

[3] San Paolo Hosp, Dept Neurol, Savona, Italy

来源：

MUSCLE & NERVE | 2004年 / 29卷 / 05期

关键词：

D O I：

10.1002/mus.20024

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：748 / 749

页数：2

共 13 条

[1] Mycophenolate mofetil and its mechanisms of action [J].

Allison, AC ;

Eugui, EM .

IMMUNOPHARMACOLOGY, 2000, 47 (2-3) :85-118

[2] Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases [J].

Chaudhry, V ;

Cornblath, DR ;

Griffin, JW ;

O'Brien, R ;

Drachman, DB .

NEUROLOGY, 2001, 56 (01) :94-96

[3] Mycophenolate mofetil for myasthenia gravis: An open-label pilot study [J].

Ciafaloni, E ;

Massey, JM ;

Tucker-Lipscomb, B ;

Sanders, DB .

NEUROLOGY, 2001, 56 (01) :97-99

[4] Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial [J].

Gaubitz, M ;

Schorat, A ;

Schotte, H ;

Kern, P ;

Domschke, W .

LUPUS, 1999, 8 (09) :731-736

[5] Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy [J].

Hughes, R ;

Bensa, S ;

Willison, H ;

Van den Bergh, P ;

Comi, G ;

Illa, I ;

Nobile-Orazio, E ;

van Doorn, P ;

Dalakas, M ;

Bojar, M ;

Swan, A .

ANNALS OF NEUROLOGY, 2001, 50 (02) :195-201

[6] INTEROBSERVER AGREEMENT IN THE ASSESSMENT OF MUSCLE STRENGTH AND FUNCTIONAL ABILITIES IN GUILLAIN-BARRE-SYNDROME [J].

KLEYWEG, RP ;

VANDERMECHE, FGA ;

SCHMITZ, PIM .

MUSCLE & NERVE, 1991, 14 (11) :1103-1109

[7] Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis [J].

Mowzoon, N ;

Sussman, A ;

Bradley, WG .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 185 (02) :119-122

[8]

Saperstein DS, 2001, MUSCLE NERVE, V24, P311, DOI 10.1002/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO

[9]

2-A

[10] CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment [J].

Trotti, A ;

Colevas, AD ;

Setser, A ;

Rusch, V ;

Jaques, D ;

Budach, V ;

Langer, C ;

Murphy, B ;

Cumberlin, R ;

Coleman, CN ;

Rubin, P .

SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (03) :176-181

← 1 2 →